The Power of the Pod

Hosted by Nancy Hanna

Eric Benjamin is an employee of Insulet Corporation. The opinions shared in the podcast are his own.

Recorded live at the ADA Conference in Orlando, Florida. Dive into the future of diabetes management with Eric Benjamin, Insulet’s Chief Product & Customer Experience Officer. In this episode, Eric reveals the innovative journey behind Omnipod, highlighting our relentless focus on customer needs and top-tier performance with every Pod change.

Discover how we're revolutionizing Automated Insulin Delivery with our wearable, tubeless Pod, and learn how these advancements simplify life for people with diabetes.

Don't miss this insider's perspective on transforming care through cutting-edge technology.

Time stamps

8:18 – The secure T2D study led to Omnipod’s type 2 clearance. Dive into the results including exciting reductions in A1C
10:45 – Hear how Omnipod 5 is creating a totally unbiased set of real-world evidence and how it compares to the results in the pivotal trial
13:12 – Get a sneak peek into what else is coming from Insulet!

 

See more episodes
This podcast provides general information and discussions about health and related subjects. This information and other content provided in this podcast, or in any linked materials, are not intended and should not be construed as medical advice, nor is the information a substitute for professional medical expertise or treatment. If you or any other person has a medical concern, you should consult your health care provider or seek other professional medical treatment. Never disregard professional medical advice or delay in seeking it because of something that you have heard in this podcast or read in any linked materials. The opinions and views expressed on this podcast and website have no relation to those of any academic, hospital, health practice or other institution.

Please consult the Omnipod® 5 Automated Insulin Delivery System User Guide for more information.

The Omnipod 5 Automated Insulin Delivery System is a single hormone insulin delivery system intended to deliver U-100 insulin subcutaneously for the management of type 1 diabetes in persons aged 2 and older & type 2 diabetes in persons aged 18 years and older. The Omnipod 5 System is intended for single patient use. The Omnipod 5 System is indicated for use with NovoLog®, Humalog®, and Admelog®. Refer to the Omnipod 5 Automated Insulin Delivery System User Guide and www.omnipod.com/safety for complete safety information including indications, contraindications, warnings, cautions, and instructions. Warning: DO NOT use SmartAdjust technology for individuals under 2 years of age or use less than 5 U of insulin per day. DO NOT start to use the Omnipod 5 System or change settings without adequate training and guidance from a healthcare provider. Initiating and adjusting settings incorrectly can result in over-delivery or under-delivery of insulin, which could lead to hypoglycemia or hyperglycemia.